Major Depressive Disorder
Conditions
Brief summary
Major depression is a prevalent and impairing illness. To better understand the basic science and treatment of depression, the investigators study the behavioral and brain processes associated with learning in depression and how potential disruptions in learning may be repaired. Understanding different methods that change learning may lead to novel treatments that contribute to recovery in people with depression.
Detailed description
Major depressive disorder ranks among the most significant causes of mortality and disability in the world. Recent data from the investigators and others highlight that impairments in reward and loss learning are central to depression, have distinct neural substrates, and improve with successful treatment. Together, these findings suggest an urgent need to delineate the relationships among neural and behavioral learning impairments and depression. Equally important, these insights suggest new targets for treatment such that manipulating the neural and behavioral substrates of learning may facilitate symptom change in depression. To address these issues, the investigators use functional neuroimaging and a computational psychiatry framework to i) systematically characterize the neural and behavioral substrates that attend reward- and loss- learning in depression and ii) assess the degree to which learning in depression responds to two behavioral methods that target learning in different ways. The investigators test the broad hypotheses that i) that depression may be characterized by distinct neural and behavioral disruptions of learning, and ii) these disruptions and associated symptoms may be ameliorated through different methods of guiding learning. Recent advances in computational psychiatry provide a mechanism-based framework within which to understand the nature and trajectory of potential learning impairments in depression and suggest new ways that disrupted learning and associated symptoms may be improved in depression
Interventions
BEHAVIORALStandard Learning
Participants will complete repeat sessions of a computer-based learning task, and task performance and symptoms will be assessed.
BEHAVIORALGuided Learning: Instructed statistics
Participants will complete repeat sessions of a computer-based learning task, and task performance and symptoms will be assessed.
BEHAVIORALGuided Learning: Changing statistics
Participants will complete repeat sessions of a computer-based learning task, and task performance and symptoms will be assessed.
Sponsors
National Institute of Mental Health (NIMH)
Virginia Polytechnic Institute and State University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
Yes
Inclusion criteria
* males and females of all ethnicities * meet diagnostic criteria for major depression or non-depressed control (assessed by study staff) * ages 18-55 * fluent in English * able to see computer display clearly * able to provide informed consent * able to follow verbal or written instructions * for participants who are referred by a clinician, a letter from that clinician indicating that participation in the study does not constitute an elevated medical or behavioral risk to the participant will be requested.
Exclusion criteria
* current pregnancy or menopause * claustrophobia * MRI contraindications * psychotic or bipolar disorder
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Task performance | approximately 6 weeks (pre- post- learning task changes and interim time points) | behavioral measures of learning task performance including accuracy, learning rate |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Neuroimaging measures | approximately 6 weeks (pre- post- learning task changes and interim time points) | functional MRI during learning task performance |
| Symptoms | approximately 6 weeks (pre- post- learning task changes and interim time points) | self-report questionnaires and clinician-obtained symptom measures |
Countries
United States
Outcome results
None listed